![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Takeda Pharmaceutical Company Licenses Global Rights to Theravance Biopharma’s TD-8954
Takeda and Theravance Biopharma, Inc. announced that the companies have entered into a global license, development and commercialization agreement for TD-8954, a selective 5-HT4...
Drug Research
GSKs Bexsero achieves primary and secondary endpoints with reduced 3-dose schedule in safety and immunogenicity study in infants and children
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1  comparing safety and immunogenicity with different dosing schedules in infants and young...
Drug Research
Nplate Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia
Amgen announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate in children with symptomatic immune thrombocytopenia. ...
Drug Research
Amgen Astellas Biopharma and Astellas Introduce new treatment option for the high cholesterol patients
 FIrst PCSK9 Inhibitor in Japan,Providing A new TREATMENT option for certain patients who have high risk in cardiovascular events and do not adequately...
Drug Research
Baxter announced the launch of a ready-to-use VANCOMYCIN Injection in sodium chloride for US
Only Manufacturer to Offer the Antibiotic in a Ready-to-Use Premixed Presentation World pharma today/Press releases /-Advancing Baxter’s longstanding commitment to provide...
Drug Research
Boehringer Ingelheim and Eli Lilly company plans to conduct Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure
New studies will evaluate the effect of JARDIANCE for the treatment of chronic heart failure There are approximately 26 million people worldwide,...
Articles
Top 5 Ways to Avoid Drug Errors
Every month millions of Americans pick up their prescription at the pharmacy, only to discover that their pill looks different than the month before....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read